Altitude Crest Partners Inc.
- SEC CIK
- 0001986035
- Latest filing
- Feb 14, 2025
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 0
- −30 vs. Q1 2024
- Portfolio value
- $0
- −$233.6M (−100.0%) vs. Q1 2024
This filing reports no long positions.
Sold out since Q1 2024 (30)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| LEGNLegend Biotech Corp | SPONSORED ADS | 652,732 | $36.6M | 15.7% | History |
| DHRDanaher Corp | Stock | 108,700 | $27.1M | 11.6% | History |
| BBIOBridgeBio Pharma, Inc. | COM | 612,060 | $18.9M | 8.1% | History |
| STVNStevanato Group S.p.A. | ORD SHS | 550,000 | $17.7M | 7.6% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 287,277 | $16.9M | 7.2% | History |
| TMOThermo Fisher Scientific Inc. | Stock | 18,400 | $10.7M | 4.6% | History |
| AVBPArriVent BioPharma, Inc. | COM | 555,555 | $9.92M | 4.2% | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 205,166 | $8.79M | 3.8% | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 400,441 | $7.90M | 3.4% | History |
| JANXJanux Therapeutics, Inc. | COM | 193,300 | $7.28M | 3.1% | History |
| LLYEli Lilly & Co | Stock | 9,200 | $7.16M | 3.1% | History |
| BHVNBiohaven Ltd. | COM | 118,380 | $6.47M | 2.8% | History |
| IMNMImmunome Inc. | COM | 262,284 | $6.47M | 2.8% | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 128,842 | $6.34M | 2.7% | History |
| GERNGeron Corp | COM | 1,531,400 | $5.05M | 2.2% | History |
| ICLRIcon PLC | COM | 14,800 | $4.97M | 2.1% | History |
| MRUSMerus N.V. | COM | 109,837 | $4.95M | 2.1% | History |
| ROIVRoivant Sciences Ltd. | SHS | 454,766 | $4.79M | 2.1% | History |
| DNLIDenali Therapeutics Inc. | COM | 209,613 | $4.30M | 1.8% | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 103,703 | $4.07M | 1.7% | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 113,100 | $3.31M | 1.4% | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 195,497 | $3.23M | 1.4% | History |
| ALGSAligos Therapeutics, Inc. | COM | 2,844,681 | $2.79M | 1.2% | History |
| ENGNenGene Therapeutics Inc. | COM | 120,289 | $2.04M | 0.9% | History |
| APLTApplied Therapeutics, Inc. | COM | 259,700 | $1.77M | 0.8% | History |
| ZYMEZymeworks Inc. | COM | 145,581 | $1.53M | 0.7% | History |
| MGXMetagenomi Therapeutics, Inc. | COM | 133,333 | $1.41M | 0.6% | History |
| TRMLTourmaline Bio, Inc. | COM | 47,400 | $1.09M | 0.5% | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 200 | $29.9K | <0.1% | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 384,573 | $12.5K | <0.1% | – |